Wuhan Hvsen Biotechnology Co.,Ltd.

¥17.61As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300871Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (9.55%)
Div yield 3.41%
ROE 14.65%
Biotechnology
Beta (5Y) 0.68
PE TTM 11.33
TSR TTM (18.59%)
Mkt cap ¥3.529B
ROIC 11.81%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥18
1.78%
44.61%
Hold 8|6|3|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.40
0.41
0.43
0.44
23.31%
16.73%
15.37%
11.34%
Revenue¥M
465.8
479.8
498.8
483.9
8.88%
7.56%
11.40%
3.76%
Peers (US$529.0M)
Cap (US$)
PE
526.1M
63.33x
Capital
TTM
5Y
10Y
Leveragex
0.944
0.255
0.198
EBIT/Intx
1.044
0.082
0.086
Own earn%
(174.31)
31.13
31.45
Sh yield%
48.90
28.30
30.50
Owners
Insiders/Inst%
1.77
86.24
Short interest%
2.20
SBC / revenue%
2.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–28
$1 testx
—
Incr. ROIC%
5